Latest Apolipoprotein B Stories
A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA.
It is known that high levels of low-density lipoprotein (LDL) cholesterol increase the risk for coronary heart disease. Now, researchers have discovered further insights about how a certain gene variant uses two mechanisms to reduce cholesterol.
Among individuals without known cardiovascular disease (CVD), the addition of certain apolipoproteins and lipoproteins to risk scores containing total cholesterol and high-density lipoprotein cholesterol (HDL-C) was associated with slight improvement in CVD prediction.
Levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin-treated patients appears to be associated with the risk of developing a major cardiovascular event, such as a heart attack or stroke, as are levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B.
ANY LAB TEST NOW®’s Advanced Heart Health Screening Tests Can Detect What the Standard, Run of the Mill Lipid Test Cannot Alpharetta,
Coronary patients with low levels of an immune system antibody called anti-PC, which neutralizes parts of the 'bad' cholesterol, run a greater risk of suffering complications following an acute cardiac episode and thus of premature death.
- A political dynamiter.